Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 9/20 | 0.74 |
| ▸ | MAOB | P27338 | 9/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | BCHE | P06276 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25194887 | 1.00 | MAPT (1.00) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL30383370 | 1.00 | MAPT (1.00) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL6263785 | 1.00 | MAPT (1.00) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL30277220 | 1.00 | MAPT (1.00) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL30792835 | 0.90 | MAPT (0.82) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL25219836 | 0.87 | MAOB (0.89) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL25191373 | 0.87 | MAOB (0.89) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL25233412 | 0.87 | MAOB (0.89) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL25195966 | 0.87 | MAOB (0.89) | MAPTKMT2AMAPK1MEN1TDP1 | |
| SCHEMBL25196735 | 0.85 | MAPT (0.74) | MAPTKMT2AMAPK1MEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023181073-A1 | MOLECULAR SINGLE-CRYSTAL PHOTONIC MICRO-RESONATORS AND METHOD OF FABRICATING THEREOF | UNIVERSITY OF HYDERABAD (IN) | 2023-09-28 | — | — | WO | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| CN-115745936-B | Fluorescent compound, preparation method thereof and application of fluorescent compound as fluorescent probe | 中国科学院大连化学物理研究所 | 2024-02-23 | — | — | CN | disclosed |
| WO-2023181073-A1 | MOLECULAR SINGLE-CRYSTAL PHOTONIC MICRO-RESONATORS AND METHOD OF FABRICATING THEREOF | UNIVERSITY OF HYDERABAD (IN) | 2023-09-28 | — | — | WO | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-115745936-A | Fluorescent compound, preparation method thereof and application of fluorescent compound as fluorescent probe | 中国科学院大连化学物理研究所 | 2023-03-07 | — | — | CN | disclosed |
| CN-112110968-B | Aggregation-induced fluorescence molecule modified nucleotide and application thereof in DNA sequencing and SNPs detection | 北京师范大学 | 2021-06-15 | — | — | CN | disclosed |
| CN-112110968-A | Aggregation-induced fluorescence molecule modified nucleotide and application thereof in DNA sequencing and SNPs detection | 北京师范大学 | 2020-12-22 | — | — | CN | disclosed |
| US-20020008465-A1 | Novel organic boron compound, process for producing the compound and organic luminescnece device using the compound | CANON KABUSHIKI KAISHA (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1138683-A2 | Novel organic boron compound, process for producing the compound and organic luminescence device using the compound | CANON KABUSHIKI KAISHA (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-4571409-A | ANTIARRHYTHMIA AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1986-02-18 | — | — | US | disclosed |
| EP-0075207-B1 | AMINOPROPANOL DERIVATIVES OF 2-HYDROXY-BETA-PHENYL PROPIOPHENONES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1986-02-05 | — | — | EP | disclosed |
| US-4540697-A | ANTIARRHYTHMIA AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1985-09-10 | — | — | US | disclosed |
| US-4461907-A | Amino-substituted flavans useful as anti-viral agents | BURROUGHS WELLCOME CO. | 1984-07-24 | — | — | US | disclosed |
| EP-0075207-A2 | Aminopropanol derivatives of 2-hydroxy-beta-phenyl propiophenones, processes for their preparation and therapeutic agents containing them | BASF Aktiengesellschaft (DE) | 1983-03-30 | — | — | EP | disclosed |
| EP-0004579-B1 | FLAVANS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-08-18 | — | — | EP | disclosed |
| EP-0051061-A2 | Novel intermediates and process for their preparation | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-05-05 | — | — | EP | disclosed |
| EP-0004579-A1 | Flavans, process for their preparation and pharmaceutical compositions containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885KMT2A 2792/4885MAPK1 3352/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885KMT2A 3188/4885MAPK1 3412/4885 |
| US-20020008465-A1 | Novel organic boron compound, process for producing the compound and organic luminescnece device using the compound | ARL1, RUVBL1, ARRB1 | MAPT 4397/4885KMT2A 3420/4885MAPK1 106/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885KMT2A 3188/4885MAPK1 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.